Eyewire News: The Podcast

Outlook Wins Appeal for Wet AMD Drug Candidate Lytenava

4 min · 27. maj 2026
Billede af episoden Outlook Wins Appeal for Wet AMD Drug Candidate Lytenava

Beskrivelse

Outlook Therapeutics takes a major step forward in its plan to gain approval for wet AMD drug Lytenava; the first commercial FLIGHT procedures using the ViaLuxe Laser System are performed in Europe; and Oculus introduces a new AI-assisted tool designed to help clinicians evaluate MGD using meibography images. Learn more about your ad choices. Visit megaphone.fm/adchoices [https://megaphone.fm/adchoices]

Kommentarer

0

Vær den første til at kommentere

Tilmeld dig nu og bliv en del af Eyewire News: The Podcast-fællesskabet!

Kom i gang

1 måned kun 9 kr.

Derefter 99 kr. / måned · Opsig når som helst

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

Alle episoder

101 episoder